# The Study of Pharmacokinetics and Pharmacodynamics of Huperzine a Injection in Healthy Chinese Subjects

> **NCT06570655** · PHASE1 · COMPLETED · sponsor: **Wanbangde Pharmaceutical Group Co., LTD** · enrollment: 12 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Huperzine A injection
- **DRUG:** Huperzine A injection

## Key facts

- **NCT ID:** NCT06570655
- **Lead sponsor:** Wanbangde Pharmaceutical Group Co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-16
- **Primary completion:** 2024-06-20
- **Final completion:** 2024-08-29
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06570655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06570655, "The Study of Pharmacokinetics and Pharmacodynamics of Huperzine a Injection in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06570655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*